发明名称 4-HYDROXI-KUMARINFORENINGAR TILL ANVENDNING FOR BEKEMPNING AV GNAGARE
摘要 1,193,500. Coumarin derivatives. LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE. 12 Dec., 1967 [13 Dec., 1966; 13 Nov., 1967], No. 56507/67. Heading C2C. The invention comprises compounds of the general Formula I wherein R represents a thienyl radical optionally substituted by an alkyl group of 1-4 carbon atoms or a nitro group or a halogen atom, and R 1 represents an alkyl group of 1-4 carbon atoms or a phenyl or biphenyl radical optionally substituted by a halogen atom or a nitro group. They are prepared by reducing a ketone of the general formula wherein R and R 1 are as defined above, with aluminium isopropylate in isopropanol. 3 - (4<SP>1</SP> - hydroxy - 3<SP>1</SP> - coumarinyl) - 3 - (5<SP>11</SP> - methyl - 2<SP>11 </SP>- thienyl) - propiophenone is prepared by reacting 4-hydroxy coumarin with 1 - phenyl - 3 - (5<SP>11</SP> - methyl - 2<SP>11</SP>- thienyl - 1 - 2 - propen - 1 - one, which is prepared by reacting acetophenone with 5-methyl thenaldehyde. The 3 - (4<SP>1 </SP>- hydroxy - 3<SP>1</SP> - coumarinyl) - 3 - (5<SP>11</SP> - halo - 2<SP>11</SP> - thienyl) - p - halo - halophenyl)- propiophenones are prepared by reacting 4- hydroxy coumarin with the corresponding 1 - p - halo - (or p 1 - halophenyl) - phenyl - 3 - (5<SP>1</SP> - halo 2<SP>1</SP>- thienyl) - 2 - propen - 1 - one which is prepared by reacting the corresponding 5<SP>1</SP>-halo- 2-thenaldehyde with the corresponding p-halo (or p<SP>11</SP>-halophenyl) acetophenone. 3 - (4<SP>1</SP> - hydroxy - 3<SP>1</SP>- coumarinyl) - 3 - (2<SP>1</SP> - thienyl) - p - nitropropiophenone is prepared from 4-hydroxy coumarin and 1-p-nitrophenyl- 3 - (2<SP>1</SP> - thienyl) - 2 - propen - 1 - one. 3 - (4<SP>1 </SP>- hydroxy - 3<SP>1</SP> - coumarinyl) - 3 - (5<SP>11</SP>- bromo - 2<SP>11 </SP>- thienyl) - p- (4<SP>1</SP>- nitrophenyl) - propiophenone is prepared by reacting 4-hydroxycoumarin with 51-bromo-thenylidene-p- (4<SP>1</SP>-nitrophenyl) -acetophenone. Pharmaceutical compositions comprising as active ingredient a compound of Formula I together with a pharmaceutically acceptable carrier are administered orally and have anticoagulant activity of the anti-vitamin K type.
申请公布号 SE395145(B) 申请公布日期 1977.08.01
申请号 SE19720015171 申请日期 1969.11.18
申请人 * LIPHA LYONNAISE INDUSTRIELLE PHARMACEUTIQUE 发明人 E * BOSCHETTI;D * MOLHO;L * FONTAINE
分类号 C07D311/12;A01N43/16;A61K31/37;C07D311/42;C07D409/06;E04G21/26;(IPC1-7):01N9/28;07D311/56 主分类号 C07D311/12
代理机构 代理人
主权项
地址
您可能感兴趣的专利